[HTML][HTML] GC/MS and LC/MS-based tissue metabolomic analysis detected increased levels of antioxidant metabolites in colorectal cancer

M Kibi, S Nishiumi, T Kobayashi… - Kobe Journal of …, 2019 - ncbi.nlm.nih.gov
Late-stage colorectal cancer is resistant to current treatments. Understanding the biological
processes responsible for the development and progression of colorectal cancer could aid …

Ibuprofen inhibits colitis-induced overexpression of tumorrelated Rac1b

P Matos, L Kotelevets, P Jordan, V Gonçalves… - Neoplasia, 2013 - Elsevier
The serrated pathway to colorectal tumor formation involves oncogenic mutations in the
BRAF gene, which are sufficient for initiation of hyperplastic growth but not for tumor …

Therapeutic targeting of inflammation and tryptophan metabolism in colon and gastrointestinal cancer

S Santhanam, DM Alvarado, MA Ciorba - Translational Research, 2016 - Elsevier
Colorectal cancer (CRC) is the third most common cancer worldwide and the second
leading cause of cancer death in the United States. Cytotoxic therapies cause significant …

[HTML][HTML] Metabolic Rewiring in Cancer: Small Molecule Inhibitors in Colorectal Cancer Therapy

D Masci, M Puxeddu, R Silvestri, G La Regina - Molecules, 2024 - mdpi.com
Alterations in cellular metabolism, such as dysregulation in glycolysis, lipid metabolism, and
glutaminolysis in response to hypoxic and low-nutrient conditions within the tumor …

[PDF][PDF] Channelling of arginine in NO and polyamine pathways in colonocytes and consequences

F Blachier, AM Davila, R Benamouzig, D Tome - Front Biosci, 2011 - article.imrpress.com
Introduction 3. Metabolism and physiological effects of polyamines and nitric oxide on
normal and cancerous colonic epithelial cells 3.1. Metabolism of L-arginine in the polyamine …

Chemopreventive action of non-steroidal anti-inflammatory drugs on the inflammatory pathways in colon cancer

P Ghanghas, S Jain, C Rana, SN Sanyal - Biomedicine & Pharmacotherapy, 2016 - Elsevier
Non-steroidal anti-inflammatory drugs (NSAIDs) are emerging as novel chemopreventive
agents against a variety of cancers owing to their capability in blocking the tumor …

[HTML][HTML] The role of nitric oxide pathway in arginine transport and growth of IPEC-1 cells

H Xiao, L Zeng, F Shao, B Huang, M Wu, B Tan, Y Yin - Oncotarget, 2017 - ncbi.nlm.nih.gov
L-Arginine itself and its metabolite-nitric oxide play great roles in intestinal physiology.
However, the molecular mechanism underlying nitric oxide pathway regulating L-Arginine …

[HTML][HTML] Hypoxia-induced NOS1 as a therapeutic target in hypercholesterolemia-related colorectal cancer

W Qiu, L Zhao, H Liu, P Xu, C Qian - Cancer & Metabolism, 2024 - Springer
Background It is well established that hypercholesterolemia increases the risk of
atherosclerosis, especially because it reduces the availability of nitric oxide (NO). However …

Angiostatic properties of sulindac and celecoxib in the experimentally induced inflammatory colorectal cancer

V Vaish, H Piplani, C Rana, SN Sanyal - Cell biochemistry and biophysics, 2013 - Springer
Initiation of various cancers has been observed to be regulated via a prolonged
inflammatory state in the tissues. However, molecular role of such a localized inflammation …

Reactive oxygen species (ROS) are a key determinant of cancer's metabolic phenotype

S Rodic, MD Vincent - International journal of cancer, 2018 - Wiley Online Library
Cancer cells exhibit a wide range of metabolic phenotypes, ranging from strict aerobic
glycolysis to increased mitochondrial respiration. The cause and utility of this metabolic …